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IMPORTANCE Community-based surveys find that many otherwise healthy individuals report
histories of hallucinations and delusions. To date, most studies have focused on the overall
lifetime prevalence of any of these psychotic experiences (PEs), whichmight mask important
features related to the types and frequencies of PEs.
OBJECTIVE To explore detailed epidemiologic information about PEs in a large multinational
sample.
DESIGN, SETTING, AND PARTICIPANTS Weobtained data from theWorld Health Organization
World Mental Health Surveys, a coordinated set of community epidemiologic surveys of the
prevalence and correlates of mental disorders in representative household samples from 18
countries throughout the world, from 2001 through 2009. Respondents included 31 261
adults (18 years and older) who were asked about lifetime and 12-month prevalence and
frequency of 6 types of PEs (2 hallucinatory experiences and 4 delusional experiences). We
analyzed the data fromMarch 2014 through January 2015.
MAIN OUTCOMES ANDMEASURES Prevalence, frequency, and correlates of PEs.
RESULTS Mean lifetime prevalence (SE) of ever having a PE was 5.8% (0.2%), with
hallucinatory experiences (5.2% [0.2%]) muchmore common than delusional experiences
(1.3% [0.1%]). More than two-thirds (72.0%) of respondents with lifetime PEs reported
experiencing only 1 type. Psychotic experiences were typically infrequent, with 32.2% of
respondents with lifetime PEs reporting only 1 occurrence and 31.8% reporting only 2 to 5
occurrences. We found a significant relationship between havingmore than 1 type of PE and
havingmore frequent PE episodes (Cochran-Armitage z = −10.0; P < .001). Lifetime
prevalence estimates (SEs) were significantly higher among respondents in middle- and
high-income countries than among those in low-income countries (7.2% [0.4%], 6.8%
[0.3%], and 3.2% [0.3%], respectively; χ22 range, 7.1-58.2; P < .001 for each) and among
women than amongmen (6.6% [0.2%] vs 5.0% [0.3%]; χ21 = 16.0; P < .001). We found
significant associations with lifetime prevalence of PEs in themultivariate model among
nonmarried compared with married respondents (χ22 = 23.2; P < .001) and among
respondents who were not employed (χ24 = 10.6; P < .001) and who had low family incomes
(χ23 = 16.9; P < .001).
CONCLUSIONS AND RELEVANCE The epidemiologic features of PEs aremore nuanced than
previously thought. Research is needed that focuses on similarities and differences in the
predictors of the onset, course, and consequences of distinct PEs.
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I n recent years, interest in the epidemiologic landscape ofhallucinations and delusions has grown.1,2 These psy-chotic experiences (PEs) are reported by a sizeable minor-
ity of the general population. A recent meta-analysis based
on 61 studies2 reported that the median lifetime prevalence
of PE was 7.2%. Because this prevalence is substantially
higher than the lifetime morbid risk for psychotic disorders,
such as schizophrenia (median morbid risk, 0.7%),3 the field
of psychiatric epidemiology has been forced to rethink how
PEs fit into the epidemiologic landscape of psychotic disor-
ders. The terms used to describe these experiences have also
evolved over time. Although psychoticlike experiences has
been used, we will use the general term psychotic experiences
to encompass hallucinatory experiences (HEs) and delusional
experiences (DEs).2
Earlywork on the epidemiologic features of PEs4 focused
on these experiences as risk indicators for later conversion to
full psychosis. This typeof researchhas an appealing logic be-
causemany of the risk factors associatedwith PEs are also as-
sociated with schizophrenia and psychosis.5 Additional evi-
dence has accumulated that PEs are also associated with the
subsequent onset of a wide array of common mental disor-
ders, includinganxiety,mood, andsubstanceusedisorders,6-8
andwith an increased risk for suicidal ideation and intent.9-11
Thus, awareness is growing that the presence of PEs may re-
flect a vulnerability to a wide range of adverse mental health
outcomes (inaddition topsychoticdisorders).4,12-16These find-
ings and the concern that antipsychotics may be inappropri-
ately used to treat individuals with isolated PEsmay have in-
fluencedthedecision toexcludeattenuatedpsychosis syndrome
in recently revised diagnostic criteria.17
As the empirical data have accumulated, systematic
reviews2,15,18,19 have pooled prevalence estimates and ap-
plied meta-regression techniques to explore the sociodemo-
graphic correlatesofPEs.These reviewsprovidevaluable clues
to the nature of PEs but also highlight important gaps in the
literature. Four of these gaps are of special importance for the
present study.
First, the use of pooling in systematic reviews of PEs has
encouraged theuseof coarsedichotomousmeasures (eg,pres-
enceor absenceof lifetimeprevalence) toharmonize thewide
arrayof scales anddiagnostic instrumentsused to assessPEs.2
This dichotomy has reduced the subtlety of the associations
examined in these reviews. Second, the studies included in the
systematic reviews have varied in many key design ele-
ments. As noted by Linscott and van Os,2 substantial hetero-
geneity in the data has hampered analyses related to the re-
lationshipbetweenPEsandsociodemographicvariables.Third,
most of the community studies of PE prevalence and corre-
lates have been performed in high-income countries. Amajor
exception is theWorld Health Survey, which included 4 brief
PE questions in surveys of 52 nations.20 However, the World
Health Survey assessment of PEs had several limitations (eg,
it lacked information on the frequency of PE occurrence, and
questions about DEs were not asked in a fashion that ex-
cluded experiences related to alcohol, illicit drugs, or sleep).
Finally, to allow pooling of data from different studies, some
reviews have collapsed different variables across orthogonal
axes. For example, Kaymaz et al15 compiled composite vari-
ables related to weak and strong PEs that in theory could be
built fromdata related to (1) the countofdifferent typesofPEs,
(2) the frequencyof occurrence, (3) associateddistress, (4) co-
morbidity, and/or (5) certainty (eg, confidence in the psy-
chotic nature of the experience).
Leading commentators have repeatedly called for more
fine-grained analyses of PEs to guide the field.1,21 The present
report provides initial results of analyses designed to address
theabove limitationsbyexaminingdata collected in theWorld
Health Organization World Mental Health (WMH) surveys, a
seriesofpopulation-basedsurveysadministered inmanycoun-
tries using consistent instruments and field procedures de-
signed to facilitatepooledcross-national analysesof thepreva-
lence and correlates of mental disorders. These data provide
an unprecedented opportunity to explore the epidemiologic
landscape of PEs.
Methods
Participants
TheWMHsurveys are a coordinated set of community epide-
miologic surveys administered in probability samples of the
householdpopulation incountries throughout theworld (http:
//www.hcp.med.harvard.edu/wmh/).Datawerecollected from
2001 through 2009. Eighteen of the 26 completed WMH sur-
veys administered theComposite InternationalDiagnostic In-
terview (CIDI) psychosis module. These 18 countries are dis-
tributed across North and South America (Colombia,Mexico,
Peru, Brazil [São Paulo], and the United States), Africa (Nige-
ria), the Middle East (Iraq and Lebanon), Asia (People’s Re-
public of China [Shenzhen]), the South Pacific (New Zea-
land), and Europe (Belgium, France, Germany, Italy, the
Netherlands, Portugal, Romania, and Spain). All 18 surveys
were based onmultistage, clustered-area probability, house-
hold sampling designs (Table 1). The weighted mean re-
sponserateacrossall 18countrieswas72.1%.Mostsurveyswere
based on nationally representative sample frames, but a few
excluded rural areas (ie, Colombia andMexico) or focused on
particular regions (ie,Nigeria andChina) or cities (Brazil). Par-
ticipatingsitesweregrouped into3country-level incomestrata
according toWorldBankcriteria22,23 as low-and lowermiddle–
income countries (Colombia, Iraq, Nigeria, China, and Peru),
uppermiddle–incomecountries (Brazil, Lebanon,Mexico, and
Romania), and high-income countries (the European coun-
tries, New Zealand, and the United States). The age ranges re-
ported herein include 18 years and older except in 3 countries
(Mexico, Colombia, and Peru) in which 65 years was the up-
per age limit.
In keepingwithprevious studies of PEs,10,12,24-29wemade
the a priori decision to exclude individuals who had PEswith
positive findings of a screen for possible schizophrenia and/or
psychosis and manic depression and/or mania (ie, respon-
dents who reported schizophrenia, psychosis, or manic de-
pression and/ormania in response to the question, “What did
thedoctor saywas causing this/these experiences?” and those
who ever took any antipsychotics for these symptoms). This
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process resulted in the exclusion of 140 respondents (0.4%of
all respondents), leaving 31 261 respondents for this study
(Table 1).
Measures and Assessments
All WMH surveys were conducted face to face in the homes
of respondents by trained lay interviewers.Written informed
consent was obtained before beginning the interviews in all
countries. Procedures forobtaining informedconsent andpro-
tecting individuals (ethical approval)wereapprovedandmoni-
tored for compliance by the institutional reviewboards of the
collaborating organizations in each country.30 Full details of
these procedures are described elsewhere.31,32
All WMH interviews had 2 parts. Part 1 was administered
to all respondents and contained assessments related to core
mental disorders. Part 2 included additional information rel-
evant to awide range of survey aims, including assessment of
PEs. All respondents who met criteria for any part 1 DSM-IV
mental disorder and a probability sample of other respon-
dents were administered part 2. Respondents to part 2 were
weightedby the inverseof theirprobabilityof selection forpart
2 to adjust for differential sampling.Within thedifferent sites,
Table 1. WMH Sample Characteristics by Income Categories and Final Sample for PEsa
Country by Income Levelb Sample Characteristicsc,d Field Dates Age Range, y
Sample Size, No. of Respondents
Response Rate, %ePart 1 With PE
Low and Lower Middle
Colombia All urban areas of the country 2003 18-65 4426 722 87.7
Iraq Nationally representative 2006-2007 18-96 4332 4329 95.2
Nigeria 21 of the 36 states in the country 2002-2003 18-100 6752 1417 79.3
PRCf Shenzhen metropolitan area 2006-2007 18-88 7132 2468 80.0
Peru Nationally representative 2004-2005 18-65 3930 530 90.2
Total NA NA NA 26 572 9466 84.7
Upper Middle
Brazil São Paulo metropolitan area 2005-2007 18-93 5037 2922 81.3
Lebanon Nationally representative 2002-2003 18-94 2857 1029 70.0
Mexico All urban areas of the country 2001-2002 18-65 5782 715 76.6
Romania Nationally representative 2005-2006 18-96 2357 2357 70.9
Total NA NA NA 16 033 7023 75.8
High
Belgium Nationally representative 2001-2002 18-95 2419 319 50.6
France Nationally representative 2001-2002 18-97 2894 301 45.9
Germany Nationally representative 2002-2003 18-95 3555 408 57.8
Italy Nationally representative 2001-2002 18-100 4712 617 71.3
Netherlands Nationally representative 2002-2003 18-95 2372 348 56.4
New Zealandf Nationally representative 2003-2004 18-98 12 790 7263 73.3
Portugal Nationally representative 2008-2009 18-81 3849 2053 57.3
Spain Nationally representative 2001-2002 18-98 5473 1159 78.6
United States Nationally representative 2002-2003 18-99 9282 2304 70.9
Total NA NA NA 47 346 14 772 65.5
Total NA NA NA 89 951 31 261 72.1
Abbreviations: NA, not applicable; PRC, People’s Republic of China;
PEs, psychotic experiences; WMH,World Mental Health.
a Exclusions are described in the Participants subsection of theMethods
section; 31 261 respondents remained after exclusions.
bBased on data from theWorld Bank Data and Statistics 2008.22
c Surveys were administered by the Colombian National Study of Mental Health,
Iraq Mental Health Survey, Nigerian Survey of Mental Health andWell-being,
La Encuesta Mundial de SaludMental en el Peru, Lebanese Evaluation of the
Burden of Ailments and Needs of the Nation, Mexico National Comorbidity
Survey, Romania Mental Health Survey, European Study of the Epidemiology
of Mental Disorders, New ZealandMental Health Survey, Portugal National
Mental Health Survey, and US National Comorbidity Survey Replication.
dMost WMH surveys are based on stratified, multistage, clustered-area
probability household samples in which samples of areas equivalent to
counties or municipalities in the United States were selected in the first stage,
followed by 1 or more subsequent stages of geographic sampling (eg, towns
within counties, blocks within towns, households within blocks) to arrive at a
sample of households, in each of which a listing of household members was
created and 1 or 2 people were selected from this listing to be interviewed. No
substitution was allowed when the originally sampled household resident
could not be interviewed. These household samples were selected from
census area data in all countries other than France (where telephone
directories were used to select households) and the Netherlands (where
postal registries were used to select households). Several WMH surveys
(Belgium, Germany, and Italy) usedmunicipal resident registries to select
respondents without listing households. Thirteen of the 18 surveys are based
on nationally representative household samples.
e The response rate is calculated as the ratio of the number of households in
which an interviewwas completed to the number of households originally
sampled, excluding from the denominator households known to be ineligible
because of being vacant at the time of initial contact or because the residents
were unable to speak the designated languages of the survey. The weighted
mean response rate is 72.1%.
f For the purposes of cross-national comparisons, we limit the sample to those
older than 18 years.
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questions related to PEs were administered to all respon-
dents or a randomsampleof those administeredpart 2.Analy-
ses in this study were based on the weighted part 2 sub-
sample of respondents administered the CIDI psychosis
module. Additional weights were used to adjust for differen-
tial probabilities of selection within households and for non-
response and tomatch the samples to sociodemographic dis-
tributions in the population.
The instrument used in the WMH surveys was the World
Health Organization CIDI,33 a validated, fully structured diag-
nostic interview designed to assess the prevalence and corre-
lates of a wide range ofmental disorders according to the defi-
nitions and criteria of the diagnostic systems of the DSM-IV34
and International Statistical Classification of Diseases, 10th
Revision.
The CIDI psychosis module included questions about the
following 6 PE types: 2 related to HEs (visual and auditory
hallucinations) and 4 related to DEs (2 bizarre delusional
items [thought insertion and/or withdrawal and mind control
and/or passivity] and 2 paranoid delusional items [ideas of
reference and plot to harm and/or follow]) (eTables 1 and 2 in
the Supplement). For example, respondents were asked if
they ever experienced PEs (eg, “Have you ever heard any
voices that other people said did not exist?”). This question
was followed by a probe question to determine whether the
reported PEs ever occurred when the person was not “dream-
ing or half-asleep or under the influence of alcohol or drugs.”
Only responses of the latter type are considered herein. The
sequence of these follow-up probe types differed slightly
between the first 6 WMH surveys, which were administered
in Europe (Belgium, France, Germany, Italy, the Netherlands,
and Spain), and those in the remaining 12 countries (eTables 1
and 2 in the Supplement).
Respondents who reported PEs were then asked about
the presence of the PEs in the past 12 months and the fre-
quency and/or occurrences of the PEs in their lifetime. In
this study, we present prevalence estimates for any PE, any
HE (with or without associated DEs), any DE (with or with-
out associated HEs), pure HEs (without DEs), and pure DEs
(without HEs). In addition, we will present the following 2
key PE-related metrics: (1) count of types of PEs (henceforth
referred to as PE type metric) and (2) frequency of occur-
rence of PE episodes (henceforth referred to as PE frequency
metric). Respondents may have had more than 1 hallucina-
tion and/or delusion type associated with a single episode of
PE. For the PE frequency metric, reported frequency of life-
time PE episodes was divided into the following 5 categories:
1 time only, 2 to 5 times, 6 to 10 times, 11 to 100 times, and
101 times or greater. This 5-category scheme was collapsed
into 1 to 10 vs 11 or more times in the analyses of sociodemo-
graphic correlates of PE frequency among respondents with
lifetime PEs.
The sociodemographic factors considered herein include
sex, age, number of years of education, employment history,
marital status, family income, andnativity (ie, born inside the
country of assessment). For the bivariate and multivariate
analyses, the sociodemographic variableswere stratified into
broad categories based onmethods described elsewhere.30
Statistical Analysis
Data were analyzed from March 2014 through January 2015.
Weighted prevalence estimates were calculated for the vari-
ous PE types and related metrics. Odds ratios and design-
corrected95%CIs are reported.Because theWMHsurveydata
featured geographic clustering and weighting, SEs of param-
eter estimates were generated using the design-based Taylor
series linearization method35 implemented in a commer-
ciallyavailablemacro (SAS,version9.4;SASInstitute, Inc).Mul-
tivariate significancewas evaluated usingWald χ2 tests based
on design-corrected coefficient variance-covariance matri-
ces. The association between the PE type metric and the PE
frequencymetric was evaluated using the Cochran-Armitage
test.36 Statistical significancewasevaluatedconsistentlyusing
2-tailed .05-level tests.
Results
Prevalence of PEs
Table 2 presents country-specific lifetime PE prevalence esti-
mates. Lifetime prevalence (SE) of at least 1 PE was reported
by 5.8% (0.2%) of the 31 261 respondents. Lifetime preva-
lence of any HE was 5.2% (0.2%); of any DE, 1.3% (0.1%). The
median (interquartile range)of lifetimePEs,HEs, andDEswere
5.5% (2.8%-7.5%), 4.4%(1.8%-6.5%), and 1.3% (0.9%-1.8%), re-
spectively (eFigures 1-3 in the Supplement present the cumu-
lative distribution of PE, HE, andDE estimates, respectively).
Twelve-month prevalence (SE) of any PE was 2.0% (0.1%),
whereas the median (interquartile range) was 1.4% (1.0%-
2.8%).
Lifetime prevalence (SE) of PEs was significantly higher
among women than men (6.6% [0.2%] vs 5.0% [0.3%];
χ21 = 16.0; P < .001). Similar sex differences were found for
prevalence of HEs (5.9% [0.2%] vs 4.3% [0.3%]; χ21 = 19.4;
P < .001) but not DEs (1.4% [0.1%] vs 1.3% [0.1%]; χ21 = 0.3;
P = .61). The significant sex difference was also found for
respondents with pure HEs (5.2% [0.2%] vs 3.7% [0.3%];
χ21 = 19.3; P < .001) but not pure DEs (0.7% [0.1%] vs 0.7%
[0.1%]; χ21 = 0.1; P = .80).
Significant differences were found across the 3 country-
level income strata in lifetime prevalence of any PE, any HE,
andanyDE. Ineachcomparison, theprevalenceestimateswere
significantly higher among respondents inmiddle- and high-
income countries than among those in low-income countries
(χ22 range, 7.1-58.2; P < .001 for each) (Table 2).
Prevalence of Individual PEs and the Distribution
of the PE TypeMetric
Table 3 shows the lifetime prevalence estimates (SE) of indi-
vidualPEtypesandcountsofdifferentPEtypes.Themostcom-
mon PE type overall was visual hallucinations (3.8% [0.2%]),
followed by auditory hallucinations (2.5% [0.1%]). Preva-
lence estimates of individual DE typeswere low (0.3%-0.7%).
Among those with any lifetime PE, 72.0% (representing 4.2%
of the total sample) reported only 1 PE type; 21.1% (represent-
ing 1.2% of the total sample), exactly 2 types; and 6.8% (rep-
resenting 0.4% of the total sample), 3 or more types.
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Distribution of the PE FrequencyMetric and the
Relationship Between PE Type and FrequencyMetrics
Psychotic experiences were typically infrequent, with 32.2%
of the respondents with lifetime PEs reporting only 1 episode
(Table4).Anadditional 31.8%of respondentswith lifetimePEs
experienced only 2 to 5 PE episodes. Thus, for nearly two-
thirds of respondents (64.0%) with lifetime PEs, these expe-
riences occurred only 1 to 5 times in their lives. An additional
10.0% of respondents with lifetime PEs reported 6 to 10 life-
timeepisodes; 20.0%, 11 to 100episodes; and6.0%, 101ormore
episodes.The relationshipbetween thePE typemetric and the
PE frequency metric is best displayed in Table 5. Those re-
spondents with more PE types are disproportionately more
likely to have more PE episodes (Cochran-Armitage z, −10.0;
P < .001).
Associations Between Sociodemographic FactorsWith
Lifetime PEs, HEs, and DEs
eTable 3 in the Supplement shows the association of sociode-
mographic variableswith lifetime PEs, HEs, andDEs in bivar-
iate and multivariate models. The following sociodemo-
graphic variables were associated with increased odds ratios
for PEs, HEs, and DEs in bothmodels: (1) being a homemaker
or classified ashavingother employment (eg, looking forwork
or disabled) vs employed (for PEs, multivariate model,
χ24 = 10.6;P < .001); (2) beingnonmarried (ie, nevermarriedor
separated, widowed, or divorced) vs married (for PEs, multi-
variatemodel, χ22 = 23.2;P < .001); and (3) lowervshighhouse-
hold income level (for PEs, multivariate model, χ23 = 16.9;
P < .001). In addition to these findings, several sociodemo-
graphicvariableswereassociatedwithonly 1 typeofPE.Young
respondents (aged 18-29 years) were significantlymore likely
tohaveDEs (comparedwiththoseolder than60years),whereas
age was unrelated to HEs (and overall PEs). Although female
sexwasassociatedwithan increasedprevalenceofPEs (inboth
models), this finding was driven by an increased risk for HEs
(but not DEs). Low educational level, in comparison, was as-
sociated with an increased risk for DEs (but not HEs). Unex-
pectedly, those born outside the country (ie, migrants) were
significantly less likely than thenative born to reportHEs (but
not DEs) in the bivariate andmultivariate models.
Associations of Sociodemographic FactorsWith PE Type
and PE FrequencyMetrics
Among the factors that influence the PE typemetric (in those
who had experienced PEs) in the multivariate model, the 3
younger strata (ie, spanning 18-59 years) were significantly
more likely tohavemore than 1 PE type (comparedwith those
aged≥60years) (eTable4 in theSupplement).Noneof theother
sociodemographic characteristicswas associatedwith the PE
type metric. Among the correlates of the PE frequency met-
ric, student statuswassignificantlyassociatedwitha lower fre-
Table 2. Lifetime and 12-Month Prevalence of PEs in theWMHSurveys
Country by Income
Levela
Prevalence, No. (%) [SE]b
Total Sample, No.
of Respondentsc
Lifetime
12-mo PEAny PE Any HE Any DE
Low and lower middle
Colombia 73 (7.5) [1.2] 68 (7.1) [1.2] 11 (0.9) [0.3] 25 (2.1) [0.5] 722
Iraq 51 (1.2) [0.2] 46 (1.1) [0.2] 13 (0.4) [0.2] 25 (0.7) [0.2] 4329
Nigeria 39 (2.2) [0.5] 32 (1.7) [0.4] 16 (1.0) [0.4] 15 (1.0) [0.4] 1417
PRC 151 (5.3) [0.8] 116 (3.8) [0.6] 54 (1.8) [0.4] 45 (1.4) [0.3] 2468
Peru 36 (6.4) [1.4] 33 (6.1) [1.4] 7 (1.1) [0.4] 18 (3.3) [0.9] 530
Total 350 (3.2) [0.3] 295 (2.6) [0.2] 101 (0.9) [0.1] 128 (1.2) [0.2] 9466
Upper middle
Brazil 548 (14.9) [0.9] 471 (13.3) [0.9] 183 (3.6) [0.3] 230 (5.6) [0.4] 2922
Lebanon 37 (1.9) [0.4] 30 (1.6) [0.4] 14 (0.6) [0.3] 15 (0.9) [0.4] 1029
Mexico 53 (4.1) [1.0] 49 (3.6) [0.9] 12 (0.8) [0.4] 22 (1.4) [0.4] 715
Romania 24 (1.0) [0.4] 21 (0.9) [0.4] 5 (0.1) [0.1] 9 (0.3) [0.1] 2357
Total 662 (7.2) [0.4] 571 (6.4) [0.4] 214 (1.7) [0.1] 276 (2.7) [0.2] 7023
High
Belgium 32 (8.3) [2.5] 19 (5.0) [1.6] 20 (5.7) [2.3] 11 (4.1) [2.4] 319
France 27 (5.7) [1.4] 23 (4.9) [1.3] 7 (1.6) [0.6] 6 (1.3) [0.7] 301
Germany 25 (2.8) [0.5] 16 (1.8) [0.4] 13 (1.3) [0.3] 6 (1.0) [0.2] 408
Italy 38 (4.5) [0.8] 31 (3.5) [1.0] 16 (1.9) [0.6] 12 (1.3) [0.5] 617
The Netherlands 47 (10.8) [2.5] 41 (10.1) [2.5] 11 (1.6) [0.5] 13 (3.0) [1.2] 348
New Zealand 724 (6.9) [0.4] 667 (6.5) [0.4] 134 (0.9) [0.1] 271 (2.4) [0.2] 7263
Portugal 140 (5.2) [0.7] 106 (3.9) [0.5] 66 (2.6) [0.5] 43 (1.7) [0.3] 2053
Spain 91 (6.7) [1.5] 77 (5.8) [1.5] 35 (1.4) [0.4] 19 (0.9) [0.2] 1159
United States 249 (8.6) [0.9] 232 (8.2) [0.9] 41 (1.3) [0.2] 79 (2.8) [0.4] 2304
Total 1373 (6.8) [0.3] 1212 (6.2) [0.3] 343 (1.4) [0.1] 460 (2.2) [0.2] 14 772
All 2385 (5.8) [0.2] 2078 (5.2) [0.2] 658 (1.3) [0.1] 864 (2.0) [0.1] 31 261
Abbreviations: DE, delusional
experience; HE, hallucinatory
experience; PRC, People’s Republic of
China; PE, psychotic experience;
WMH,World Mental Health.
a Based on data from theWorld Bank
Data and Statistics 2008.22
bNumbers indicate the unweighted
number of respondents who
reported the PEs. Prevalence
estimates are based on weighted
data. PEs indicate any of 6 types;
HEs, any of 2 types; and DEs, any of
4 types.
c Indicates the total unweighted
number of respondents whowere
asked about PEs.
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quency of PE occurrence. None of the other sociodemo-
graphic variables was associatedwith PE frequency (eTable 5
in the Supplement).
Discussion
Based on cross-national samples from 18 countries,we found
that 5.8%of respondents reportedhaving 1ormorePEsat least
once in their lifetimeand2.0%inthepreviousyear.Theseover-
all estimates are broadly consistent with those in the previ-
ous literature.2 Our study contributes important new infor-
mation regarding the count of PE types and frequency of PEs
that gobeyond the issues considered inprevious community-
based studies of PEs. Perhaps themost striking finding is that
PEs are infrequent for most of the individuals who experi-
ence them,with 32.2% reporting 1 PE episode in their life and
64.0% reporting no more than 5 lifetime occurrences. In the
general population, thosewith 2 ormore types of PEs are also
significantly more likely to have more PE episodes. For ex-
ample, of thosewho reported 3 ormore PE types, nearly one-
quarter (24.5%) reported 101 or more occurrences.
Our findings provide an empirical foundation onwhich to
investigate factors that influence thepersistenceofPEs.1When
viewedwithinthecontextof thegapbetween12-monthandlife-
timePEestimates fromthepresent study (ie, 2.0%vs5.8%),we
caninfer thatmost individualsdonothavepersistentPEs(mind-
ful that lifetime prevalence estimates for mental health disor-
dersareoftenbiaseddownwardowingtounderreporting).37Lin-
scottandvanOs2estimatedthatof those individualswhoreport
any PEs, approximately 80%wouldhavehad transient experi-
ences.Thisestimate isconsistentwithourempirical findingthat
about 64.0% of individuals with PEs report only 1 to 5 lifetime
occurrences.
Basedon the set of PEs examined, our study confirms that
HEsweremore commonthanDEs (5.2%vs 1.3%), and this gen-
eral patternwas consistent across the 3 country-level income
strata. Lifetime prevalence of PEs was lower in the low-
income to lower middle–income countries (3.2%) compared
with the upper middle–income and high-income countries
(7.2% and 6.8%, respectively). Although we cannot compare
our results directly with the single previous cross-national
study of PEs20 owing to differences in how the PEs were as-
sessed, both studies (optimized for consistent design and PE
assessment) provided insights in variation between sites.
One of the strengths of cross-national studies, such as the
WMHSurvey, is that theyareable to identify risk factors thatex-
istconsistentlyacrosscountriesdespitesite-specificcultural fac-
tors.We found an increased prevalence of HEs andDEs associ-
atedwithbeingunmarriedornot employedandhavinga lower
household income level. However, certain demographic fea-
turesweredifferentiallyassociatedwithHEsbutnotDEsandvice
versa. For example, women had a significantly higher preva-
lenceofHEsbutnotDEs.Wefoundasignificant relationshipbe-
tween being younger and having DEs but not HEs. Unexpect-
edly,migrants inourstudyweresignificantly less likely toreport
lifetime HEs (compared with native-born respondents). These
novel findingsprovide importantpointsofdistinctionbetween
the epidemiologic features of psychotic disorders and PEs.5,38
Although several sociodemographic variables were sig-
nificantly associatedwith the lifetimeprevalenceofPEs, these
featureswerenot associatedwith thePE typemetric or thePE
frequencymetric.We speculate that comorbid psychiatric ill-
ness (eg, depression andanxiety disorders) andother risk fac-
torsknowntobeassociatedwithPEsandmentaldisorders (eg,
familyhistory, substanceuse, and traumaexposure)maycon-
tribute to these PE-related metrics. The comprehensive na-
ture of theWMHsurveywill allowus to explore thesehypoth-
eses in future analyses.
Although our study has many strengths (eg, large sample
size, range of countries, uniformmethods for data collection,
and innovative analysis of PE-related metrics), several limita-
tions are notable. In keepingwith other population-based sur-
veys, we relied on trained lay interviewers to administer the
questionnaire.Althoughweexcludedthoseindividualswhohad
screen-positive findings forpossiblepsychoticdisorders,wedid
not have access to valid measures of clinical psychotic disor-
ders. Lifetime prevalence estimates are prone to underre-
porting.37Weonlyassessed4typesofDEs,andtheseprobesmay
have been insensitive to culture-specific delusional beliefs.16
Conclusions
We have provided, to our knowledge, the most comprehen-
sive description of the epidemiologic landscape of PEs pub-
lished todate.Although the lifetimeprevalenceofPEs is 5.8%,
Table 3. Lifetime Prevalence of Individual PEs in theWMHSurveys
Typea
Lifetime Prevalence,
No. (%) [SE]b
HE
Visual 1545 (3.8) [0.2]
Auditory (verbal) 1051 (2.5) [0.1]
Any 2078 (5.2) [0.2]
DE
Thought insertion and/or withdrawal 193 (0.4) [0.0]
Mind control and/or passivity 148 (0.3) [0.0]
Ideas of reference 209 (0.4) [0.0]
Plot to harm and/or follow 328 (0.7) [0.1]
Any 658 (1.3) [0.1]
PE
Any 2385 (5.8) [0.2]
No. of PE types
1 1631 (4.2) [0.2]
2 544 (1.2) [0.1]
≥3 210 (0.4) [0.0]
Allc 31 261 (100)[0.0]
Abbreviations: DE, delusional experience; HE, hallucinatory experience;
PE, psychotic experience; WMH,World Mental Health.
a PEs indicate any of 6 types; HEs, any of 2 types; and DEs, any of 4 types.
bNumbers indicate the unweighted number of respondents who reported the
PEs. Prevalence estimates are based on weighted data.
c Indicates the total unweighted number of respondents whowere asked about
PEs.
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these events are typically rare. For nearly one-third of indi-
viduals who have PEs (ie, 32.2%), these events were solitary
(ie, 1 event only). In the general population, a small subgroup
of individuals hasmultiple typesof PEs andexperiences these
types of PEsmore frequently. The research community needs
to leverage this fine-grained information to better determine
howPEs reflect risk status.Our studyhighlights the subtle and
variegatednatureof theepidemiologic featuresofPEsandpro-
vides a solid foundation on which to explore the bidirec-
tional relationship between PEs andmental health disorders.
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Table 4. Frequency of LifetimeOccurrence of PEs Among RespondentsWho Reported Ever Having 1 orMore PEs in theWMHSurveys
Sample by Type
PE Frequency Metric
Row Sample
Size, No.a
Prevalence by No. of PEs, % (SE)b
1 2-5 6-10 11-100 ≥101
Non-ESEMed
Visual HE 1379 31.9 (1.7) 32.0 (1.7) 10.5 (1.0) 18.7 (1.4) 6.7 (0.9)
Auditory (verbal) HE 965 20.8 (1.9) 31.7 (2.2) 11.1 (1.3) 26.5 (1.9) 9.9 (1.3)
Any HE 1871 30.4 (1.4) 32.4 (1.4) 10.0 (0.8) 20.6 (1.3) 6.6 (0.8)
Thought insertion and/or withdrawal
DE
162 28.9 (4.1) 27.1 (3.9) 9.7 (2.0) 15.6 (2.9) 18.8 (3.3)
Mind control and/or passivity DE 136 27.1 (5.0) 18.2 (3.5) 11.8 (2.5) 24.2 (4.5) 18.8 (4.6)
Ideas of reference DE 169 15.5 (2.6) 24.5 (4.5) 13.2 (2.8) 23.7 (4.0) 23.1 (5.2)
Plot to harm and/or follow DE 278 36.4 (3.5) 26.2 (2.8) 12.6 (2.2) 18.7 (2.4) 6.0 (1.8)
Any DE 556 29.1 (2.5) 27.6 (2.1) 12.6 (1.5) 18.2 (1.8) 12.5 (2.0)
Any PEc 2125 31.7 (1.4) 31.9 (1.3) 10.1 (0.7) 20.0 (1.2) 6.4 (0.7)
1 PE typec 1452 37.5 (1.7) 32.3 (1.5) 8.9 (0.8) 18.0 (1.4) 3.3 (0.7)
2 PE typesc 491 16.7 (3.3) 35.3 (3.6) 12.8 (2.5) 24.9 (2.5) 10.3 (1.9)
≥3 PE typesc 182 17.2 (2.8) 17.6 (3.5) 13.8 (3.4) 25.6 (3.9) 25.8 (4.3)
ESEMedc
Any PE 260 36.4 (3.3) 30.7 (2.9) 9.5 (1.5) 20.3 (2.3) 3.2 (0.9)
1 PE type 179 43.0 (3.9) 29.6 (3.7) 4.3 (1.4) 21.0 (2.1) 2.1 (0.9)
2 PE types 53 23.6 (8.6) 33.7 (4.7) 32.3 (5.7) 6.8 (1.3) 3.6 (1.4)
≥3 PE types 28 2.1 (0.6) 34.0 (12.1) 2.5 (1.0) 48.2 (12.5) 13.2 (5.6)
Allc
Any PE 2385 32.2 (1.3) 31.8 (1.2) 10.0 (0.7) 20.0 (1.1) 6.0 (0.6)
1 PE type 1631 38.1 (1.5) 32.0 (1.4) 8.4 (0.7) 18.3 (1.2) 3.2 (0.6)
2 PE types 544 17.4 (3.1) 35.1 (3.3) 14.6 (2.3) 23.2 (2.2) 9.7 (1.8)
≥3 PE types 210 15.6 (2.5) 19.3 (3.3) 12.7 (3.1) 27.9 (3.9) 24.5 (3.9)
Abbreviations: DE, delusional experience; ESEMeD, European Study of the
Epidemiology of Mental Disorders; HE, hallucinatory experience; PE, psychotic
experience; WMH,World Mental Health.
a Indicates the unweighted number of respondents who reported PEs.
b Prevalence estimates are based on weighted data.
c Types include any of 6.
Table 5. Cross-Table of PE FrequencyMetric and PE TypeMetric in theWMHSurveys
PE Type
Metrica
Row Sample
Size, No.b
PE Frequency Metric
Prevalence by No. of PEs, % (SE)c Cochran-
Armitage z
Statistic
P Value for
z Statisticd χ2 Test
P Value
for χ2d,e1 2-5 ≥6
1 1631 38.1 (1.5) 32.0 (1.4) 29.9 (1.5)
−10.0 <.001 32.1 <.001
≥2 754 16.9 (2.4) 31.2 (2.6) 51.8 (2.9)
Abbreviations: PE, psychotic experience; WMH,World Mental Health.
a Includes any of 6 types.
b Indicates the unweighted number of respondents who reported PEs in all
countries.
c Prevalence estimates are based on weighted data.
d Significant at .05 level, 2-sided test.
e Indicates df of 2.
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